Asthma News and Research RSS Feed - Asthma News and Research Twitter

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

When asthmatics come into contact with something that irritates their lungs, three main changes occur that prevent air from moving easily through the airways. The bands of muscle surrounding the airways tighten and narrow the airway (bronchospasm), the lining of the airways inflame, and the cells that line the airways produce more mucus. This bronchospasm, inflammation, and mucus production lead to wheezing, coughing and difficulty in breathing.

An asthma “attack” refers to when the onset of symptoms is severe. In rare cases, an asthma attack can be life threatening and hospitalization may be required to provide emergency treatment.
The exact cause of asthma is not yet clear, but examples of factors that are known to trigger the condition include allergens such as house dust mites or pollen, cigarette smoke, exercise, chest infections, and exposure to cold air.

Asthma cannot be cured but it can be controlled. One of the most important parts of asthma control is identifying asthma triggers so they can be avoided wherever possible. Medications that may be used include anti-inflammatories to reduce swelling and mucus production and bronchodilators to relax the muscles that tighten and narrow the airways.
CPS students and staff received EAIs for acute allergic reactions

CPS students and staff received EAIs for acute allergic reactions

During the 2012-2013 school year, 38 Chicago Public School (CPS) students and staff were given emergency medication for potentially life-threatening allergic reactions. [More]
Newborns of mothers who smoke during pregnancy have altered stress hormones, DNA

Newborns of mothers who smoke during pregnancy have altered stress hormones, DNA

Researchers from The Miriam Hospital have studied the effects of smoking during pregnancy and its impact on the stress response in newborn babies. Their research indicates that newborns of mothers who smoke cigarettes during pregnancy show lower levels of stress hormones, lowered stress response, and alterations in DNA for a gene that regulates passage of stress hormones from mother to fetus. [More]
Regeneron, Sanofi announce initiation of dupilumab Phase 3 study in adults with atopic dermatitis

Regeneron, Sanofi announce initiation of dupilumab Phase 3 study in adults with atopic dermatitis

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis (AD) that is not adequately controlled with topical AD medications. [More]
Children infected with enterovirus more likely to have type 1 diabetes

Children infected with enterovirus more likely to have type 1 diabetes

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that children who have been infected with enterovirus are 48% more likely to have developed type 1 diabetes. The study is by Dr Tsai Chung-Li, China Medical University, Taiwan, and colleagues. [More]
Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines. [More]
Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF). [More]
Consultant Live unveils new online sleep disorders educational program for doctors, nurses

Consultant Live unveils new online sleep disorders educational program for doctors, nurses

UBM Medica US announces that Consultant Live a leading online community for primary care clinicians, has unveiled a new online sleep disorders educational program to help doctors and nurses help their patients get a good night's rest. [More]
Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Cumberland Pharmaceuticals Inc. today announced that preoperative intravenous ibuprofen improved overall quality of recovery in patients undergoing laparoscopic cholecystectomy surgery. These results will be presented at the American Anesthesiology 2014 Annual Meeting in New Orleans, Louisiana. [More]
Grand Challenges Canada announces 11 seed grants to improve mental health in developing countries

Grand Challenges Canada announces 11 seed grants to improve mental health in developing countries

On the day the world is collectively raising awareness on mental health issues, Grand Challenges Canada, funded by the Government of Canada, announced new funding for 11 novel ideas to improve mental health in developing countries, one of the biggest unmet needs of our time. Seed grants of up to $270,000 are awarded to 11 innovators from Canada and low- and middle-income countries, totalling $2.9 million CAD. [More]
Views on giving flu shot to younger children

Views on giving flu shot to younger children

It's a common question parents ask themselves this time of year: Does my child really need a flu shot? Though the flu may seem harmless, the truth is on average 20,000 children age 5 and younger are hospitalized due to flu symptoms each year. [More]
Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States. [More]
Gerresheimer Q3 revenues up 2.2% to EUR 323.9m

Gerresheimer Q3 revenues up 2.2% to EUR 323.9m

Gerresheimer AG again increased revenues in the third quarter of financial year 2014. [More]
Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announced today the initiation of the pivotal Phase 3 trial (OPUS) in Germany for a rare form of bile duct cancer for which there is currently no acceptable therapy. [More]
Genetic differences influence asthma risk in Latinos

Genetic differences influence asthma risk in Latinos

Native American ancestry is associated with a lower asthma risk, but African ancestry is associated with a higher risk, according to the largest-ever study of how genetic variation influences asthma risk in Latinos, in whom both African and Native American ancestry is common. The study, led by UC San Francisco researchers, was published online October 6, 2014 in the Journal of Allergy and Clinical Immunology. [More]
Survey: Many U.S. adults support equal healthcare coverage for undocumented immigrant children

Survey: Many U.S. adults support equal healthcare coverage for undocumented immigrant children

Access to health insurance is very limited for immigrants living in the U.S. - both undocumented immigrants and permanent residents. But a new survey has found that many U.S. adults who work on behalf of children think undocumented immigrant children should have access to healthcare equal to that of U.S.-born children. [More]
CHLA reports first confirmed case of enterovirus D68 in Los Angeles

CHLA reports first confirmed case of enterovirus D68 in Los Angeles

In September, Children's Hospital Los Angeles physicians predicted it was a matter of when, and not if, Los Angeles children would become infected with Enterovirus EV-D68, commonly referred to as enterovirus D68. On Oct. 1, that day came. CHLA and public health officials announced that a young patient who had been hospitalized at CHLA with a respiratory illness and later experienced partial limb paralysis had tested positive for enterovirus D68. [More]
Researchers find new clues to how common cold can trigger asthma

Researchers find new clues to how common cold can trigger asthma

Researchers have identified a molecular mechanism that could explain why the common cold can bring on life-threatening asthma attacks. [More]
Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did not respond to intranasal corticosteroids. [More]
Allakos secures additional $10M investment to expand its development portfolio

Allakos secures additional $10M investment to expand its development portfolio

Allakos Inc. announced today that it has secured an additional $10 million investment from current investors to fund development of an additional therapeutic antibody. [More]
Individuals can improve asthma symptoms by avoiding air pollution

Individuals can improve asthma symptoms by avoiding air pollution

People who suffer from asthma may think there's not a lot they can do to control their asthma besides properly taking medications and avoiding allergic triggers. [More]